Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Dec 15,2017
Novel Technique Opens Door to Super Resolution of Single Molecules in Cells
Researchers report that they have adapted a technique called DNA-PAINT to confocal microscopes to allow them to investigate molecules deep inside cells. They describe DNA-PAINT as a molecular imaging technology to localize fluorescent dyes.   The team says it is now able to visualize a variety of different molecules, including combinations of different proteins, RNAs, and DNARead more
More
Dec 15,2017
Cancer-Causing Mutations Also Boost Tumor Immunoresistance
Mutations in the Ras gene are double trouble. Not only do they drive 25% of human cancers, they also suppress the immune system's anticancer response. Essentially, these mutations turn good cells bad, and they also help bad cells masquerade as good cells by boosting the expression of a protein called PD-L1, or programmed death-ligand 1.Read more
More
Dec 15,2017
What are the barriers to the domestic commercialization of CAR T?
Do you know the Prospects of CAR T cell therapy and What are the barriers to the domestic commercialization of CAR T? You can see this in more detail in this article.
More
What are the barriers to the domestic commercialization of CAR T?
Dec 14,2017
New Animal Model Developed to Aid Zika Studies
When battling emerging infectious diseases, finding a model that accurately recapitulates the pathogenesis of the infection is critical to developing effective therapeutic interventions. Yet, as most scientists can attest, the things that are the most critical are also most often the most difficult to obtain.
More
New Animal Model Developed to Aid Zika Studies
Dec 14,2017
Genetic Differences Could Impact Efficacy and Safety of CRISPR
Studies by researchers in the U.S. and Canada suggest that small differences in the genetic codes of individuals could have a significant impact on the efficacy, side effects and safety of treatments based on CRISPR/Cas9 gene editing. The teams at Harvard Medical School, Boston Children's Hospital, and the Université de Montréal say their findings suggestRead more
More
Dec 13,2017
Countering an Epigenetic Factor May Subdue Pancreatic Cancer
A pancreatic cancer cell can alter its identity and become more aggressive – more motile, more invasive, more resistant to chemotherapy, and more imbued with "stemness.” Such a profound shift in identity, reasoned Genentech researchers, might occur at the epigenetic level, where regulatory molecules may control the expression of many different genes. These researchers screenedRead more
More
Dec 13,2017
Feeding Overcrowded Bacteria Increases Antibiotic Susceptibility
Antibiotics are commonly ineffective against chronic, hard-to-treat infections caused by bacteria that are present at very high densities. Studies by researchers at the Massachusetts Institute of Technology (MIT) have now suggested why these overcrowded pathogenic organisms become tolerant to treatment and demonstrate how feeding the bacteria with extra nutrients to stimulate respiratory metabolism renders them moreRead more
More
Dec 12,2017
CRISPR/Cas9 Edits Epigenome with Therapeutic Efficiency
The kindest cut may be no cut or, in the case of genome editing, no double-strand break (DSB). Although a DSB in DNA is the usual result when the CRISPR/Cas9 genome-editing system is used, modified versions of CRISPR/Cas9 avoid cutting into the genome and instead manipulate the epigenome. Rather than change genes – and riskRead more
More
CRISPR/Cas9 Edits Epigenome with Therapeutic Efficiency
Dec 12,2017
Inhibiting Key Nutrient Sensing Pathway May Reverse Age-Related Stem-Cell Loss
Adult stem cells replenish dying cells and regenerate damaged tissues throughout our lifetime. We lose many of those stem cells, along with their regenerative capacity, as we age. Researchers from Stanford University, the Buck Institute, Columbia University, and the USCF School of Medicine, report that TOR, a nutrient sensing pathway which is critical to the aging process,Read more
More
Inhibiting Key Nutrient Sensing Pathway May Reverse Age-Related Stem-Cell Loss
Dec 11,2017
Cancer Drug Provides Neuroprotection for Huntington's Disease
Huntington's disease is a devastating, inevitably fatal disease, with no medications that slow or stop disease progression. A drug already used to treat certain forms of cancer may also be an effective therapy for Huntington's disease (HD), according to a new study led by investigators at the University of California, San Diego (UCSD). The sameRead more
More
Cancer Drug Provides Neuroprotection for Huntington's Disease
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->